Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
Merck
Colorcon
Johnson and Johnson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for NAMENDA XR

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for NAMENDA XR (2017)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $113,263,918
INSIDE ANOTHER STORE $265,137,470
[disabled in preview] $576,927,265
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 101,969
INSIDE ANOTHER STORE 342,304
[disabled in preview] 915,072
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICARE $661,547,457
PRIVATE INSURANCE $170,209,313
[disabled in preview] $123,571,884
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for NAMENDA XR
Drug Units Sold Trends for NAMENDA XR

Annual Sales Revenues and Units Sold for NAMENDA XR

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
NAMENDA XR   See Pricing   See Pricing 2017
NAMENDA XR   See Pricing   See Pricing 2016
NAMENDA XR   See Pricing   See Pricing 2015
NAMENDA XR   See Pricing   See Pricing 2014
NAMENDA XR   See Pricing   See Pricing 2013
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Colorcon
Dow
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.